Clinical trial Recruiting at 1 site Observational Ages 29 Days to 14

Observational study on hyperthyroidism in children

Official title: A Retrospective and Prospective Observational Study of Hyperthyroidism in Children

Run by Shengjing Hospital · NCT06570967 · Data updated 2026-11-12

This study looks at children with hyperthyroidism to see how they are diagnosed, treated, and what their long-term health outcomes are like.

Quick facts

Study typeObservational
Ages29 Days to 14 Years
SexAll
Enrollment1000 (estimated)
SponsorShengjing Hospital
Academic / other
Locations1 site (Shenyang, Liaoning)
StatusRecruiting
StartedJuly 18, 2023
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedAugust 27, 2024
Trial IDNCT06570967 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 14 years or younger with a confirmed diagnosis of hyperthyroidism.

Probably not a fit

Patients who have previously received treatment for hyperthyroidism at other hospitals or have certain medical histories may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study conducts both retrospective and prospective assessments of children diagnosed with hyperthyroidism. It aims to gather information on diagnosis, treatment, and long-term outcomes, focusing on clinical characteristics, treatment effects, side effects, and remission rates. The study will analyze predictive factors for treatment efficacy and the risk of adverse reactions related to antithyroid medications. It is a non-interventional study, meaning no new treatments will be administered; rather, existing data will be utilized.

Why it matters

Potential benefit: If successful, this study could enhance understanding of hyperthyroidism management in children, leading to improved treatment strategies.

How similar studies have gone: While this study is observational and builds on existing knowledge, similar studies have previously provided valuable insights into pediatric hyperthyroidism management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≤14 years old
2. Initial diagnosis of hyperthyroidism

Exclusion Criteria:

1. Hyperthyroidism had been treated with medication in other hospitals,
2. History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation,
3. Patients with incomplete clinical data

Where it's running

  • Shengjing Hospital of China Medical University
    Shenyang, Liaoning, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.